Osimertinib Tablets – A Breakthrough Treatment for Lung Cancer
As lung cancer continues to be one of the leading causes of cancer-related deaths worldwide, targeted therapies like Osimertinib Tablets have transformed treatment outcomes for patients diagnosed with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC). Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that offers improved efficacy, enhanced progression-free survival, and better central nervous system (CNS) penetration compared to earlier therapies.
Cordium Pharmaceuticals Pvt Ltd is committed to providing high-quality oncology medicines that support healthcare providers and patients across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What is Osimertinib?
Osimertinib is an oral targeted anticancer medication used for treating patients with EGFR mutation-positive NSCLC. It works by selectively blocking abnormal EGFR proteins that promote cancer cell growth and spread.
Trending Search Keywords:
Osimertinib Tablets
Osimertinib 80 mg
EGFR Lung Cancer Treatment
NSCLC Targeted Therapy
Best Treatment for EGFR-Mutated Lung Cancer
Third Generation EGFR Inhibitor
Lung Cancer Medicine
Osimertinib Price
Advanced NSCLC Treatment
EGFR Positive Cancer Therapy
Indications of Osimertinib Tablets
Osimertinib is prescribed for:
1. First-Line Treatment of EGFR-Mutated NSCLC
Patients with specific EGFR mutations, including:
Exon 19 deletions
Exon 21 L858R substitution mutations
2. Locally Advanced or Metastatic NSCLC
For patients whose cancer has spread beyond the lungs.
3. Adjuvant Therapy After Tumor Resection
To reduce recurrence risk after surgical removal of EGFR-positive tumors.
4. Brain Metastases Associated with NSCLC
Osimertinib effectively crosses the blood-brain barrier, making it valuable for patients with CNS involvement.
How Osimertinib Works
Cancer cells with EGFR mutations continuously receive growth signals. Osimertinib blocks these signals by targeting mutant EGFR receptors while sparing healthy cells to a greater extent than traditional chemotherapy.
Benefits of Osimertinib Treatment:
✅ Improved progression-free survival
✅ Better overall survival rates
✅ Effective against brain metastases
✅ Convenient oral administration
✅ Reduced systemic toxicity compared to chemotherapy
✅ Enhanced quality of life for patients
Recommended Dosage
The standard dosage is:
Osimertinib 80 mg tablet orally once daily
The medication can be taken:
With or without food
At the same time each day
Until disease progression or unacceptable toxicity occurs
Always follow the prescribing oncologist's recommendations.
Common Side Effects of Osimertinib
Most side effects are manageable and may include:
Diarrhea
Dry skin
Rash
Nail disorders
Fatigue
Mouth sores
Reduced appetite
Serious Side Effects Requiring Medical Attention:
Interstitial lung disease (ILD)
QT interval prolongation
Cardiomyopathy
Severe skin reactions
Eye disorders
Patients should undergo regular monitoring during treatment.
Why Osimertinib is Becoming the Preferred Choice in Global Oncology
Healthcare professionals across **Kenya, Nigeria, Ghana, Philippines, Vietnam, United Arab Emirates, Saudi Arabia, Uzbekistan, Kazakhstan, United States, United Kingdom, and South Africa are increasingly adopting Osimertinib due to:
Superior efficacy over first-generation EGFR inhibitors
Proven survival benefits
Strong performance in patients with CNS metastases
Favorable safety profile
International treatment guideline recommendations
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd – Trusted Oncology Partner
Cordium Pharmaceuticals Pvt Ltd focuses on delivering:
High-quality oncology medicines
International export capabilities
Reliable pharmaceutical supply chains
Regulatory-compliant manufacturing standards
Affordable cancer treatment solutions
Our mission is to improve access to advanced cancer therapies across emerging and developed healthcare markets.
Frequently Asked Questions (FAQs)
Is Osimertinib chemotherapy?
No. Osimertinib is a targeted therapy that specifically inhibits EGFR-mutated cancer cells.
What type of lung cancer is treated with Osimertinib?
It is primarily used for EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC).
Can Osimertinib treat brain metastases?
Yes. Osimertinib has demonstrated strong activity against CNS metastases due to its ability to penetrate the blood-brain barrier.
How long do patients take Osimertinib?
Treatment duration varies based on individual response, disease progression, and physician recommendations.
Osimertinib Tablets Supplier & Exporter | Cordium Pharmaceuticals Pvt Ltd
If you are looking for a reliable supplier of Osimertinib Tablets 80 mg, Cordium Pharmaceuticals Pvt Ltd supports healthcare providers, distributors, hospitals, and oncology centers worldwide.
